What is Shantel?
Established in 1990, Shantel operates as a full-service provider specializing in custom manufacturing and private label services for the beauty industry. The company caters to both domestic and international clients on a wholesale basis, enabling them to develop unique skin care lines. Shantel's expertise extends to innovative product development, offering effective skin care solutions such as the RxFace Professional Clinical PrePost Treatment Skin Care Line, with a particular emphasis on the medical and dermatological sectors.
How much funding has Shantel raised?
Shantel has raised a total of $34K across 1 funding round:
Debt
$34K
Debt (2021): $34K with participation from PPP
Key Investors in Shantel
PPP
Public-Private Partnership
What's next for Shantel?
With the recent influx of substantial expansion capital, Shantel is strategically positioned for significant growth. This investment, occurring at a critical Series B/C stage, will likely be directed towards enhancing manufacturing capabilities, expanding its product development pipeline, and broadening its market reach both domestically and internationally. The company's focus on custom solutions and private label services, combined with its established reputation in the medical and dermatological fields, provides a strong foundation for leveraging this new financing to solidify its market position and explore new opportunities in the competitive beauty and personal care landscape.
See full Shantel company page
